Millennium Management’s Checkpoint Therapeutics CKPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-401,816
| Closed | -$1.62M | – | 5907 |
|
|
2025
Q1 | $1.62M | Buy |
401,816
+347,630
| +642% | +$1.16M | ﹤0.01% | 3980 |
|
|
2024
Q4 | $173K | Buy |
+54,186
| New | +$184K | ﹤0.01% | 5348 |
|
|
2024
Q3 | – | Sell |
-39,212
| Closed | -$84.3K | – | 6134 |
|
|
2024
Q2 | $84.3K | Sell |
39,212
-24,221
| -38% | -$43.1K | ﹤0.01% | 5340 |
|
|
2024
Q1 | $130K | Buy |
63,433
+51,512
| +432% | +$103K | ﹤0.01% | 5513 |
|
|
2023
Q4 | $27.3K | Sell |
11,921
-9,418
| -44% | -$20.5K | ﹤0.01% | 5590 |
|
|
2023
Q3 | $36.3K | Buy |
+21,339
| New | +$48.5K | ﹤0.01% | 5543 |
|
|
2023
Q1 | – | Sell |
-36,878
| Closed | -$188K | – | 6424 |
|
|
2022
Q4 | $188K | Sell |
36,878
-18,301
| -33% | -$132K | ﹤0.01% | 5355 |
|
|
2022
Q3 | $574K | Sell |
55,179
-28,759
| -34% | -$343K | ﹤0.01% | 4841 |
|
|
2022
Q2 | $865K | Sell |
83,938
-29,445
| -26% | -$386K | ﹤0.01% | 4507 |
|
|
2022
Q1 | $2.01M | Buy |
113,383
+32,578
| +40% | +$700K | ﹤0.01% | 3877 |
|
|
2021
Q4 | $2.51M | Sell |
80,805
-3,013
| -4% | -$99.8K | ﹤0.01% | 3556 |
|
|
2021
Q3 | $2.77M | Sell |
83,818
-18,725
| -18% | -$553K | ﹤0.01% | 3537 |
|
|
2021
Q2 | $3.02M | Buy |
102,543
+89,983
| +716% | +$2.49M | ﹤0.01% | 3426 |
|
|
2021
Q1 | $394K | Sell |
12,560
-25,709
| -67% | -$862K | ﹤0.01% | 5014 |
|
|
2020
Q4 | $1.01M | Buy |
38,269
+27,379
| +251% | +$693K | ﹤0.01% | 3730 |
|
|
2020
Q3 | $292 | Buy |
10,890
+1,278
| +13% | +$30.7K | ﹤0.01% | 3858 |
|
|
2020
Q2 | $190K | Buy |
9,612
+5,208
| +118% | +$94.9K | ﹤0.01% | 3858 |
|
|
2020
Q1 | $67K | Sell |
4,404
-4,025
| -48% | -$71.2K | ﹤0.01% | 3624 |
|
|
2019
Q4 | $145K | Buy |
+8,429
| New | +$141K | ﹤0.01% | 3945 |
|
|
2019
Q3 | – | Sell |
-4,091
| Closed | -$124K | – | 4211 |
|
|
2019
Q2 | $124K | Buy |
+4,091
| New | +$161K | ﹤0.01% | 3860 |
|
|
2018
Q2 | – | Sell |
-7,539
| Closed | -$331K | – | 3818 |
|
|
2018
Q1 | $331K | Buy |
+7,539
| New | +$327K | ﹤0.01% | 3176 |
|
Millennium Management's CKPT Position: Q2 2025 in Review
Millennium Management sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 401,816 shares — an estimated $1.62M sold.
Millennium Management first reported a position in CKPT in Q1 2018 and held it in 21 quarters. The position peaked at $3.02M in Q2 2021. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.
- Millennium Management reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
- Millennium Management sold 401,816 Checkpoint Therapeutics shares in Q2 2025, an estimated $1.62M.
- Millennium Management first reported a position in Checkpoint Therapeutics in Q1 2018 and held it in 21 quarters.
- Millennium Management's Checkpoint Therapeutics position peaked at $3.02M in Q2 2021.
- 0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.
Based on Millennium Management's 13F filing for Q2 2025, filed 14 Aug 2025.